The FDA will now require clinical trials to approve boosters for healthy Americans under 65, making it unlikely the shots ...

The agency said it would approve new versions of the vaccine only for adults 65 years of age and older as well as for people with one or more risk factors for severe COVID-19 outcomes. These risk ...

The FDA is moving to restrict COVID vaccination to adults 65 and older and other particularly vulnerable people. Learn what’s ...

The FDA will continue recommending annual COVID-19 vaccines for older adults and high-risk groups, but says more clinical ...

The shift was a marked departure from previous FDA guidance, which recommended an annual COVID vaccine for everyone 6 months ...

Hi, %{firstName}% Games Car rental Federal health officials outlined plans in The New England Journal of Medicine that indicated a narrower population could have access to updated COVID-19 vaccines ...

The U.S. Food and Drug Administration (FDA) is changing the game on COVID-19 vaccines. Instead of approving yearly boosters ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious Covid-19 ...

Applied Clinical Trials is the thought leader in pharmaceutical drug development operations and clinical trial design, ...

Here’s how COVID-19 vaccine guidance is changing in the U.S. For people at high risk of severe COVID-19. The process of ...

FDA changes COVID-19 vaccine approval policy, major trials now required for widespread use. Higher risk individuals still ...